Business Context and Reporting Period
Company: Super League Enterprise, Inc. (SLE)
Filing Type: Form 8-K (Current Report)
Date of Report: September 20, 2024
Reporting Period: Event-based report regarding a financing transaction consummated on September 20, 2024.
Key Financial Metrics and Transaction Details
This filing details a private placement financing rather than periodic financial performance. Key metrics include:
- Gross Proceeds: Approximately $697,000 from the sale of 697 Units.
- Unit Composition: Each Unit consists of one share of Series AAA-3 Junior Convertible Preferred Stock and a warrant to purchase 1,000 shares of Common Stock.
- Purchase Price: $1,000 per Unit.
- Transaction Costs:
- Cash fee to Placement Agent: $69,700.
- Non-accountable expense allowance: $13,940.
- Placement Agent Warrants: 80,852 shares at $1.25 exercise price and 101,065 shares at $1.00 exercise price.
- Preferred Stock Terms:
- Stated Value: $1,000 per share.
- Initial Conversion Price: $1.25 per share.
- Dividends: 20% of underlying Common Stock shares payable on 30, 60, and 90-day anniversaries of the filing date.
- Investor Warrants: Exercisable immediately at $1.00 per share; expire three years from September 20, 2024.
Note: The filing does not provide data on revenue, net income, operating cash flow, total debt, or liquidity ratios.
Material Changes and Corporate Actions
- Capital Structure Change: Issuance of 697 shares of Series AAA-3 Junior Convertible Preferred Stock and associated warrants.
- Corporate Filings: Filed a Certificate of Designation for the new Preferred Stock and Certificates of Correction for Series AAA and Series AAA-2 Junior Convertible Preferred Stock to correct administrative errors.
- Registration Rights: Executed an agreement to file a registration statement for the resale of shares issuable upon conversion and warrant exercise within 30 days of closing.
Outlook, Risks, and Contingencies
- Stockholder Approval Requirement: Price-based anti-dilution adjustments and the "Additional Investment Right" (allowing holders to invest an additional amount equal to their initial investment at the original price) require stockholder approval. This is anticipated at the next annual meeting in November 2024.
- Dilution Risk: The transaction may result in the issuance of greater than 20% of the Company's Common Stock outstanding at a price less than the conversion price, triggering the Nasdaq stockholder approval rule.
- Liquidity and Resale: Securities are exempt from registration under Section 4(a)(2) and Rule 506(b); they cannot be sold in the U.S. absent registration or an exemption.
- Future Issuances: The "Additional Investment Right" allows for further capital raises over the next 18 months, subject to the terms of the agreement.
Investor Verification Checklist
- Verify the final closing date and actual cash proceeds received (currently contemplated on or before September 27, 2024).
- Confirm the outcome of the stockholder vote at the November 2024 annual meeting regarding anti-dilution adjustments and Additional Investment Rights.
- Review the full text of the Certificate of Designation (Exhibit 3.1) for specific beneficial ownership and primary market limitations that may restrict dividend payments or conversions.
- Monitor the filing of the registration statement for the resale of shares, which is due within 30 days of the final closing.
- Assess the impact of the 20% dividend structure on future common stock dilution.